drugset / Trial / NCT01011114

Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant

NCT01011114

Terminated 40 enrolled Montefiore Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether cinacalcet, used in patients with secondary hyperparathyroidism to control excessive parathyroid hormone, can normalize low blood phosphorus that is commonly seen in patients who have had a kidney transplant.

Timeline

Start
2009-11
Primary completion
2015-10-15
Completion
2015-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cinacalcet Other / unclassified 30 mg

Indications